← Upcoming Courses
Syn-CRM Lounge Talks
The Syn-CRM Lounge Talks is a hybrid Continuing Professional Development (CPD) event designed to engage Physicians and other healthcare professionals in an enriching conversation focused on the management of cardiovascular, renal, and metabolic (CRM) conditions. The event will feature distinguished resource persons from the fields of Diabetes, Endocrinology, and Nephrology, offering a unique blend of case-based discussions, interactive sessions, and expert presentations. The key topics include innovative approaches to improve outcomes in CRM conditions, the role of HbA1C control versus organ protection, and a deeper dive into the science behind SGLT2 inhibitors through an analysis of the EMPOWER study data.
Participants will have the opportunity to engage in a Q&A panel discussion and participate in two interactive checkpoints designed to bridge evidence and practice. This format ensures an engaging, collaborative learning experience, whether attending virtually or in person.
WHY YOU SHOULD REGISTER
This event offers a rare opportunity to learn directly from experts in the fields of Diabetes, Endocrinology, and Nephrology. By joining the Syn-CRM Lounge Talks, you will gain practical insights into managing CRM conditions holistically, stay updated on the latest evidence-based practices, and interact with peers and specialists during highly interactive sessions. Whether you are a primary care practitioner, specialist, or pharmacist, the knowledge and skills gained from this event will enhance your clinical practice and improve patient outcomes.
Event Moderator:
Target Audience: Physicians
Date: Wednesday, 2nd October 2024
Time: 4:00 PM – 5:30 PM (GMT - Ghana) | 7:00 PM – 8:30 PM (EAT - Kenya)
PROUDLY ORGANIZED AND SPONSORED BY
AGENDA
7:00 PM – 7:10 PM (EAT) | 4:00 PM – 4:10 PM (GMT)
Opening & Welcome
Case Checkpoint #1: Evidence and Practice Interactive Session (Slido)
Facilitators: BI Medical / KDSG
7:10 PM – 7:30 PM (EAT) | 4:10 PM – 4:30 PM (GMT)
Session 1: Improving Outcomes in Cardiovascular, Renal, and Metabolic Conditions in Primary Care
Topic: Holistic vs Discrete Treatment Approaches
- Moderator: Dr. Rosslyn Ngugi (KDSG Faculty)
- Speakers:
- Prof. Marc Evans (UK)
- Dr. Roberta Lamptey (Ghana)
- Prof. Ifeoma Ulasi (Nigeria)
7:30 PM – 7:50 PM (EAT) | 4:30 PM – 4:50 PM (GMT)
Session 2: HbA1C Control vs Organ Protection
Topic: Everyday GDMT Practice Points
- Speakers:
- Dr. Rosslyn Ngugi (Kenya)
- Prof. Marc Evans (UK)
- Dr. Roberta Lamptey (Ghana)
- Prof. Ifeoma Ulasi (Nigeria)
7:50 PM – 8:10 PM (EAT) | 4:50 PM – 5:10 PM (GMT)
Session 3: Making Sense of the SGLT2i Science
Topic: The EMPOWER Data in Perspective
- Speaker: Prof. Marc Evans (UK)
- Q&A Panel Discussion
- Case Checkpoint #2: Evidence and Practice Interactive Session (Slido)
All Faculty
8:10 PM – 8:30 PM (EAT) | 5:10 PM – 5:30 PM (GMT)
Closing Remarks & Dinner
Hosted by BI Medical / All live attendees
In-person attendance is at the Sarova Panafric Hotel, Nairobi, Kenya
Overview
Course Description
This hybrid CPD event brings together leading experts in Diabetes, Endocrinology, and Nephrology to explore cutting-edge approaches in managing cardiovascular, renal, and metabolic conditions. Through a combination of case-based discussions, interactive sessions, and expert presentations, participants will delve into practical strategies for improving patient outcomes in primary care. Topics such as the balance between HbA1C control and organ protection, and insights from the EMPOWER study on SGLT2 inhibitors, will be covered. The event also features an engaging Q&A panel and evidence-based checkpoints, fostering collaboration between participants and specialists.
What you will learn
By the end of this engagement, participants will be able to:
1. Understand the latest evidence-based practices in managing cardiovascular, renal, and metabolic conditions.
2. Differentiate between holistic and discrete treatment approaches in primary care.
3. Apply best practices for HbA1C control and organ protection in everyday clinical practice.
4. Analyze and interpret data from the EMPOWER study on SGLT2 inhibitors.
5. Engage in collaborative case discussions to bridge the gap between evidence and clinical practice.
Course Content
Lecture Sessions
- LIVE EVENT: Premiering on Wednesday, 2nd October, 2024 @ 1600 GMT (4:00 pm) 1hr 30 minutes
Downloadables
No downloadable content added to this course yet.
About Facilitators
- 1 Course on CES
Prof. Marc Evans
MB BCh, MD, FRCP, DipDiab, PhD
Consultant Diabetologist
University Hospital Llandough, Cardiff, UK
Prof. Marc Evans is a Consultant Diabetologist at the University Hospital Llandough in Cardiff, where he has held his position since 2003. With a distinguished career spanning over two decades, Prof.
View full profile / courses
- 1 Course on CES
Dr. Roberta Lamptey
BSc, MBChB, MSc Diabetes, PgDip Diabetes, PgCert, FWACP, FGCP, PhD
Consultant Family Physician | Diabetologist | Part-time Lecturer
Korle Bu Teaching Hospital (KBTH) | University of Ghana Medical School
Dr. Roberta Lamptey is a highly regarded Consultant Family Physician and Diabetologist at the Korle Bu Teaching Hospital (KBTH) and a part-time lecturer at the University of Ghana Medical School. With a passion for improving diabetes self-management education, Dr.
View full profile / courses
- 1 Course on CES
Dr. Rosslyn Ngugi
MD, Fellow
Consultant Physician/Endocrinologist | Vice Chair – KDSG
Kenya Diabetes Study Group
Consultant Physician, Endocrinologist Chair KAP Nairobi branch. Vice-chair KDSG MBCHB (UON). MMED IMED (UON), Pg Dip Diabetes and Endocrinology (NSW), Fellow ECSACOP
View full profile / courses
- 1 Course on CES
Prof. Ifeoma I. Ulasi
MD, FWACP; MSc. FRCP (Lond.)
Professor of Medicine
College of Medicine, University of Nigeria and the Alex Ekwueme Federal University Teaching Hospital, Nigeria
Prof. Ifeoma I. Ulasi is a professor of medicine at the College of Medicine, University of Nigeria and Alex Ekwueme Federal University Teaching Hospital. She is involved in several research initiatives and projects on kidney disease, including genomic studies and studies in hypertension.
View full profile / courses
